RecruitingPhase 2Phase 3NCT06085716

Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

Sponsor

M.D. Anderson Cancer Center

Enrollment

240 participants

Start Date

Feb 16, 2024

Study Type

INTERVENTIONAL

Conditions

Fatigue Metastatic Cancers

Summary

To find out if combining psychoeducational interventions (such as education, counseling, and self-managed therapies) with an open-label placebo can help to improve your quality of life better than either the psychoeducational interventions or the placebo alone.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Open Label Placebo, a behavioral approach called Psychoeducational Intervention, and others for people with fatigue and metastatic cancers. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.